Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Depression Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

129 recruiting trials for Depression. Eligibility criteria explained in plain English.

TrialFinderData lists 129 Depression clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 2 is the largest group at 46% (12 studies); the largest phase groups are Phase 2: 12, Phase 4: 6, Phase 1: 3, Phase 3: 3.

Research is led by Massachusetts General Hospital (4), Stanford University (3), VA Office of Research and Development (3), among the most active sponsors registered for these trials.

The most frequently studied intervention is Placebo (drug, 10 trials), followed by DT-101, Ketamine.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
129
Total Trials
129
Recruiting Now
3
Phase 3 Trials
10
Sponsors

Track Depression trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05927974

Investigating Dynamic Interactions in Distributed Cognitive Control Networks

The purpose of this study is to investigate the brain activity associated with cognitive tasks (thinking, reasoning, remembering) in order to understand how the brain works during...

Sponsor: University of Alabama at BirminghamEnrolling: 301 location
RECRUITINGNCT04526093

Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC,...

Sponsor: University Health Network, TorontoEnrolling: 10001 location
RECRUITINGNCT06772194

Taiwan Post-Stroke Disability Study

Stroke remains a major health issue in Taiwan, being the fourth leading cause of death and the top cause of disability. While past research has focused on functional outcomes at...

Sponsor: National Taiwan University HospitalEnrolling: 20001 location
RECRUITINGPhase 2NCT06073886

Personalized Brain Stimulation to Treat Chronic Concussive Symptoms

The goal of this study is to investigate a new treatment for chronic symptoms after concussion or mild traumatic brain injury in people aged 18-65 years old. Chronic symptoms...

Sponsor: University of California, Los AngelesEnrolling: 751 location
RECRUITINGNCT04610697

Cognitive Remediation in Forensic Mental Health Care

Forensic patients often display cognitive deficits, particularly in the domain of executive functions, that represent a challenge to forensic rehabilitation. One...

Sponsor: The Royal Ottawa Mental Health CentreEnrolling: 301 location
RECRUITINGPhase 4NCT04400266

Buspirone and Melatonin for Depression Following Traumatic Brain Injury

Traumatic brain injuries (TBIs) are common. Post-TBI depression is associated with anxiety, aggression, fatigue, distractibility, anger, irritability, and rumination. The current...

Sponsor: Massachusetts General HospitalEnrolling: 102 locations
RECRUITINGNCT06338215

Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality

The goal of this clinical trial is to test two advices on alcohol drinking in more than 10.000 Spanish adult drinkers (men of 50 or more years and women of 55 or more years). The...

Sponsor: Clinica Universidad de Navarra, Universidad de NavarraEnrolling: 100001 location
RECRUITINGNCT06374277

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge....

Sponsor: University of TennesseeEnrolling: 3882 locations
RECRUITINGPhase 2NCT07610473

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

In this study, researchers will learn more about a study drug called DT-101 in participants with Major Depressive Disorder (MDD), a form of depression. The goal of this clinical...

Sponsor: Draig Therapeutics LtdEnrolling: 1182 locations
RECRUITINGNCT07471529

Activating Social Resources in Psychotherapy-Seeking Individuals: Effectiveness and Timing of a Social Support...

This study evaluates a Just-In-Time Adaptive Intervention (JITAI) aiming to foster social support processes for adults with elevated depressive symptoms awaiting outpatient...

Sponsor: University of ZurichEnrolling: 1201 location
RECRUITINGNCT05681767

Motivational Multicomponent Lifestyle Interventions as a Supportive Treatment for Depression in Primary Health Care

The investigators aim to examine whether a motivational multicomponent lifestyle intervention as a supportive treatment for depression has a beneficial effect on recovery from...

Sponsor: Kuopio University HospitalEnrolling: 2101 location
RECRUITINGPhase 2NCT07022405

Stratified Pharmacological Approaches for Regulating Circuit-Level Effects

This research study aims to understand how people with depression respond to the medication pramipexole and to determine whether clinical response differs depending on the...

Sponsor: Stanford UniversityEnrolling: 601 location
RECRUITINGNCT06604481

An Online Ecoaching RCT Intervention for Carers: Enhancing Wellbeing and Resilience Through Self-Help Strategies

The goal of this three-armed, double-blind randomized controlled trial (RCT) is to compare the effectiveness of an online self-help eCoaching intervention designed for caregivers....

Sponsor: The University of Hong KongEnrolling: 2321 location
RECRUITINGPhase 2NCT06309472

Trial of Mirtazapine for Depression in IBD

This study will test whether it is feasible to conduct a clinical trial of mirtazapine (an antidepressant tablet) in patients who have both depression and inflammatory bowel...

Sponsor: King's College LondonEnrolling: 764 locations
RECRUITINGNCT06350201

Machine Learning-based Classification of Symptom Clusters and Online CBT

To breakthrough the bottleneck identified, we will conduct a cross-sectional study to develop a symptom clustering model for depression and anxiety. A wide range of statistical...

Sponsor: Wuhan Mental Health CentreEnrolling: 3801 location
RECRUITINGPhase 4NCT06903819

Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients

The goal of this clinical trial is to learn if ketamine, given during surgery, can help improve recovery for adults with serious orthopedic trauma. The study will test whether...

Sponsor: Texas Tech University Health Sciences CenterEnrolling: 902 locations
RECRUITINGNCT07556692

A Study of Home-use Brain Stimulation to Treat Bipolar Depression

Bipolar depression is a long-lasting and disabling condition, and many people continue to experience depressive symptoms despite standard treatments. Transcranial direct current...

Sponsor: King's College LondonEnrolling: 2121 location
RECRUITINGPhase 1NCT06085937

Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department

There is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to...

Sponsor: Lindsay Maguire, MDEnrolling: 502 locations
RECRUITINGNCT03665831

Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults

In this study, the investigators will be examining the effects of the deep repetitive transcranial magnetic stimulation (rTMS) using the H1 coil in patients over the age of 60...

Sponsor: Rotman Research Institute at BaycrestEnrolling: 281 location
RECRUITINGNCT06675877

Impact of Virtual Reality on Pediatric Patients with ESRD on Regular Hemodialysis Through Arteriovenous Fistula.

This case control study will be conducted to study the effectiveness of Virtual Reality technique on pain during arteriovenous cannulation and on reduction of anxiety and...

Sponsor: Tanta UniversityEnrolling: 601 location
RECRUITINGNCT06488573

PROgram To Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolar Disorder

Individuals with Bipolar Disorder (BD) have twice the risk of being affected by metabolic comorbidities and a 1.8-fold increased risk of mortality from cardiovascular diseases...

Sponsor: University of Sao PauloEnrolling: 881 location
RECRUITINGNCT07376369

Association of Spousal Support With Parenting Self-Confidence and Depression in Primipar Mothers

The transition to motherhood, particularly for first-time (primiparous) women, is a critical life period requiring substantial psychological and social adjustment. Hormonal...

Sponsor: Istanbul University - CerrahpasaEnrolling: 1931 location
RECRUITINGNCT05099341

DEPLIPIDO Study: Functional and Lipidomic Analysis of Plasma HDL in Patients With Depression Compared to Controls

Depression is a disabling condition in terms of psychosocial alteration and also in terms of physical comorbidities. Depression doubles the risk of myocardial infarction compared...

Sponsor: Centre Hospitalier Universitaire DijonEnrolling: 901 location
RECRUITINGPhase 4NCT06610305

Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression

The goal of this clinical trial is to learn how hormonal changes over the menstrual cycle affect mood symptoms in reproductive-aged women with depression that worsens during the...

Sponsor: University of North Carolina, Chapel HillEnrolling: 751 location
RECRUITINGNCT07396623

Validation of French PHQ-4 and PC-PTSD-5 Screening Scales

Mental illness is a major public health issue. It affects one in five people, represents the largest expense for health insurance (14%), is the leading cause of years lived with...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 901 location
RECRUITINGNCT04877977

Long-term Observation of Participants With Mood Disorders

Background: More than 12,000 people have taken part in research at the Experimental Therapeutics \& Pathophysiology Branch at the National Institute of Mental Health Intramural...

Sponsor: National Institute of Mental Health (NIMH)Enrolling: 10001 location
RECRUITINGNCT06879977

Body Awareness in People With Depressive Disorder

Body awareness plays a crucial role in health and well-being. However, too little research has been carried out on how it manifests in individuals with depressive disorders. The...

Sponsor: Johannes Kepler University of LinzEnrolling: 1251 location
RECRUITINGNCT06456931

A Pilot Study Comparing the Efficacy of Traditional Buddhist Mindfulness Training Versus Secular Mindfulness-based...

This interventional study is conducted with the goal of comparing the efficacy of traditional Buddhist mindfulness training versus secular mindfulness based cognitive therapy...

Sponsor: Anuradha BaminiwattaEnrolling: 601 location
RECRUITINGNCT06805851

Impact of Depression on Thermoregulation

The purpose of this study is to determine if, compared to non-depressed adults, differences exist in skin blood flow and sweating responses to passive heat stress in adults with...

Sponsor: Penn State UniversityEnrolling: 641 location
RECRUITINGPhase 2NCT07621237

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

The goal of this clinical trial is to learn if a drug called TNX-102 SL works to treat moderate to severe major depressive disorder in adults. It will also learn about the safety...

Sponsor: Tonix Pharmaceuticals, Inc.Enrolling: 36020 locations
RECRUITINGNCT06740396

Prevalence and Severity of Depression in Coronary Artery Disease Patients

This observational study aims to estimate the prevalence and severity of depression among patients with coronary artery disease (CAD) in Baghdad, Iraq, using the self-administered...

Sponsor: Al-Nahrain UniversityEnrolling: 2001 location
RECRUITINGPhase 2NCT07300969

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. Subjects will attend the clinic every...

Sponsor: Draig Therapeutics LtdEnrolling: 30020 locations
RECRUITINGPhase 2NCT05570812

Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

This study will determine the effects of pregnenolone on brain function, inflammation and depressive symptoms in people with HIV who have depression. Participants in this study...

Sponsor: Massachusetts General HospitalEnrolling: 1201 location
RECRUITINGPhase 3NCT06911112

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants...

The study will evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in participants with MDD on improving symptoms of depression.

Sponsor: Neurocrine BiosciencesEnrolling: 20010 locations
RECRUITINGNCT07105345

Exploring Efficacy of Multi-Mode Cognitive Processing Therapy (CPT) for PTSD

This study is a longitudinal, multicenter, single-blind, two-arm randomized controlled trial designed to evaluate the effectiveness of Multi-Modal Cognitive Processing Therapy...

Sponsor: Far Eastern Memorial HospitalEnrolling: 602 locations
RECRUITINGNCT05366270

Peripheral Neuroimmune Mechanisms of Hyperthermia

The goal of this study is to examine how whole-body hyperthermia affects the thermoinflammatory profile, which includes the combined immune and heat shock response, in patients...

Sponsor: Massachusetts General HospitalEnrolling: 601 location
RECRUITINGNCT06635486

Improving Mental Health in Forcibly Displaced Populations

This project aims to improve mental health support for Venezuelan migrants living in Lima, Peru, who often face challenges like anxiety, depression, and post-traumatic stress...

Sponsor: Boston Medical CenterEnrolling: 901 location
RECRUITINGPhase 2NCT06512220

Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)

Limit: 5000 characters. Psilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 121 location
RECRUITINGPhase 4NCT06004115

Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression

This mechanistic study uses an anti anxiety drug and brain imaging to study the threat processing system and associated brain circuits in people with depression, anxiety disorders...

Sponsor: Laureate Institute for Brain Research, Inc.Enrolling: 1651 location
RECRUITINGNCT06976840

Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments

The goal of this clinical trial is to learn how different types of non-invasive brain stimulation affect mood and brain function in adults with major depressive disorder (MDD). It...

Sponsor: Marta Peciña, MD PhDEnrolling: 2001 location
RECRUITINGPhase 1 / Phase 2NCT07251491

Psilocybin to Treat Depression in Spinal Cord Injury

The main goal of this study is to determine if psilocybin is safe for use in people with SCI. The study will measure how people with SCI respond to three psilocybin doses: low...

Sponsor: James J. Peters Veterans Affairs Medical CenterEnrolling: 301 location
RECRUITINGNCT05117255

Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy...

This project is designed to determine if a computer-delivered cognitive-behavioral treatment can improve the otherwise poor alcohol use disorder treatment outcomes for individuals...

Sponsor: University of MinnesotaEnrolling: 2561 location
RECRUITINGNCT07413458

Virtual Reality (VR) NATURE - Alcohol Use Disorder (AUD)

This pilot randomized clinical trial will evaluate the feasibility, acceptability, and preliminary effectiveness of immersive Virtual Reality (VR) nature intervention among adults...

Sponsor: University of MichiganEnrolling: 501 location
RECRUITINGNCT07033923

Neuro-computational Study of Thymic Fluctuations in Mood Disorders

Depression and bipolar disorder are frequent, debilitating conditions. Both are thought to be primarily caused by an impaired regulation of mood, which is why they are sometimes...

Sponsor: Centre Hospitalier St AnneEnrolling: 5882 locations
RECRUITINGNCT06633146

Stroke Rehabilitation Utilizing Therapeutical Methods Designed for Nature Environments

Outpatient participants with a recent stroke diagnoses receive complimentary rehabilitation. The nature interventions include ergo- and physiotherapeutic and neurocognitive tasks...

Sponsor: Joint Authority for Päijät-Häme Social and Health CareEnrolling: 401 location
RECRUITINGPhase 2NCT05543681

Clinical Trial on Agitation in Alzheimer's Dementia

The purpose of this study is to assess the efficacy of the oral medication IGC-AD1, a THC-based (Delta-9-Tetrahydrocannabinol) formulation administered twice a day on Agitation in...

Sponsor: IGC Pharma, LLCEnrolling: 16420 locations
RECRUITINGNCT07180407

The Post-ICU Pain Study

BACKGROUND: ICU survivors may experience serious psychological, physical and cognitive impairments following ICU admission, collectively termed Post Intensive Care Syndrome...

Sponsor: Zealand University HospitalEnrolling: 8004 locations
RECRUITINGNCT07219264

Mental Health CPR for Cancer Survivors

This is a parallel, two-arm interventional study comparing the Mental Health CPR behavioral intervention to standard community health education. The goal of this clinical trial is...

Sponsor: Ponce Medical School Foundation, Inc.Enrolling: 12601 location
RECRUITINGNCT06019377

Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care

This study will deploy a scalable secondary prevention program that leverages existing foster youth transition services to improve mental health functioning and service use before...

Sponsor: Portland State UniversityEnrolling: 1061 location
RECRUITINGNCT05555875

Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part II

This study is a clinical trial that evaluates what drives patient engagement and tests the impact of two strategies-automated motivational push messaging and coach support-to...

Sponsor: Brigham and Women's HospitalEnrolling: 761 location

Showing 50 of 129 trials.Search all Depression trials

Frequently Asked Questions

There are currently 129 clinical trials for Depression, with 129 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Depression, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 3 Phase 3 trials for Depression, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.